c-Myc is necessary for DNA damage-induced apoptosis in the G2 phase of the cell cycle

被引:87
作者
Adachi, S [1 ]
Obaya, AJ [1 ]
Han, ZY [1 ]
Ramos-Desimone, N [1 ]
Wyche, JH [1 ]
Sedivy, JM [1 ]
机构
[1] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA
关键词
D O I
10.1128/MCB.21.15.4929-4937.2001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The c-myc proto-oncogene encodes a transcription factor that participates in the regulation of cellular proliferation, differentiation, and apoptosis. Ectopic overexpression of c-Myc has been shown to sensitize cells to apoptosis. We report here that cells lacking c-Myc activity due to disruption of the c-myc gene by targeted homologous recombination are defective in DNA damage-initiated apoptosis in the G, phase of the cell cycle. The downstream effector of c-Myc is cyclin A, whose ectopic expression in c-myc(-/-) cells rescues the apoptosis defect. The kinetics of the G, response indicate that the induction of cyclin A and the concomitant activation of Cdk2 represent an early step during commitment to apoptosis. In contrast, expression of cyclins E and D1 does not rescue the apoptosis defect, and apoptotic processes in G, phase are not affected in c-myc(-/-) cells. These observations link DNA damage-induced apoptosis with cell cycle progression and implicate c-Myc in the functioning of a subset of these pathways.
引用
收藏
页码:4929 / 4937
页数:9
相关论文
共 57 条
[1]   Cyclin A/cdk2 activation is involved in hypoxia-induced apoptosis in cardiomyocytes [J].
Adachi, S ;
Ito, H ;
Tamamori-Adachi, M ;
Ono, Y ;
Nozato, T ;
Abe, S ;
Ikeda, M ;
Marumo, F ;
Hiroe, M .
CIRCULATION RESEARCH, 2001, 88 (04) :408-414
[2]   Ionizing radiation induces apoptosis and elevates cyclin A1 Cdk2 activity before but not after the midblastula transition in Xenopus [J].
Anderson, JA ;
Lewellyn, AL ;
Maller, JL .
MOLECULAR BIOLOGY OF THE CELL, 1997, 8 (07) :1195-1206
[3]  
ASKEW DS, 1991, ONCOGENE, V6, P1915
[4]   Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells [J].
Canelles, M ;
Delgado, MD ;
Hyland, KM ;
Lerga, A ;
Richard, C ;
Dang, CV ;
Leon, J .
ONCOGENE, 1997, 14 (11) :1315-1327
[5]   Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors [J].
Chang, YT ;
Gray, NS ;
Rosania, GR ;
Sutherlin, DP ;
Kwon, S ;
Norman, TC ;
Sarohia, R ;
Leost, M ;
Meijer, L ;
Schultz, PG .
CHEMISTRY & BIOLOGY, 1999, 6 (06) :361-375
[6]   Myc-mediated transformation: the repression connection [J].
Claassen, GF ;
Hann, SR .
ONCOGENE, 1999, 18 (19) :2925-2933
[7]   The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation [J].
Cole, MD ;
McMahon, SB .
ONCOGENE, 1999, 18 (19) :2916-2924
[8]  
Dang CV, 1999, MOL CELL BIOL, V19, P1
[9]   c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells [J].
Dong, JA ;
Naito, M ;
Tsuruo, T .
ONCOGENE, 1997, 15 (06) :639-647
[10]  
DUBREZ L, 1995, LEUKEMIA, V9, P1013